Jaguar Health Shares Jump 5.19% After Hours - Jaguar Health (NASDAQ:JAGX)

Jaguar Health (NASDAQ: JAGX) shares jumped 5.19% to $36.25 in after-hours trading Tuesday, extending a dramatic rally that saw the stock surge about 1,200% in the regular session. The move follows the U.S. Food and Drug Administration’s decision to waive key Prescription Drug User Fee Act fees tied to two of the company’s therapies. Jaguar said the waiver applies to Mytesi (crofelemer) delayed-release tablets for fiscal year 2027 for Mytesi’s indicated use in adults with noninfectious diarrhea associated with HIV/AIDS on antiretroviral therapy. Separately, the FDA’s Center for Veterinary Medicine waived fees for Canalevia-CA1, a dog drug for chemotherapy-induced diarrhea.